NUCLEOLIN and prostate cancer: Indeed, the expression of nucleolin is significantly enhanced in several solid tumors such as pancreatic cancer, hepatocellular carcinoma, colorectal cancer, thyroid cancer, glioma, breast cancer, prostate cancer, gastric cancer, melanoma and leukaemia [30].